CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL SETTLEMENT AND TERMINATION OF LICENSE AGREEMENTSettlement and Termination of License Agreement • May 11th, 2023 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2023 Company Industry JurisdictionThis Settlement and Termination of License Agreement (the “Settlement Agreement”) is made as of May 12, 2022 (the “Settlement Effective Date”), by and between Aytu BioPharma, Inc. (formerly known as Aytu BioScience, Inc.), a Delaware corporation, with its principal offices at 373 Inverness Parkway, Suite 206, Englewood, CO (“Aytu”), and TRIS Pharma, Inc., a New Jersey corporation, with a location at 2031 U.S. Highway 130, Monmouth Junction, NJ 08852 (“TRIS”) (collectively, the “Parties”).
SETTLEMENT AND TERMINATION OF LICENSE AGREEMENTSettlement and Termination of License Agreement • August 5th, 2016 • Atossa Genetics Inc • Surgical & medical instruments & apparatus • Virginia
Contract Type FiledAugust 5th, 2016 Company Industry JurisdictionBesins Healthcare Luxembourg SARL and its Affiliates (“Besins”) and Atossa Genetics, Inc. (“Atossa”) (collectively with Besins, the “Parties”) enter into this Settlement and Termination of License Agreement (“Termination Agreement”) as of this 4th day of August, 2016 (the “Effective Date”).